For the Culture By The Culture. ISSN: 3064-9331.
Legal cannabis is often blamed for rising traffic deaths, but federal data tells a more complicated story. NHTSA findings, toxicology limitations, and conflicting crash studies reveal that THC presence is not a reliable measure of impairment. This investigation breaks down how flawed testing and policy shortcuts have shaped the narrative around so-called stoned driving.
For decades, politicians have claimed marijuana is a gateway to heroin and harder drugs. Federal youth surveys, NSDUH data, and NIDA’s own language tell a different story. Cannabis use is widespread, hard drug use remains rare, and most users do not progress. The data dismantles one of prohibition’s most durable fear narratives.
A new cannabis study claims marijuana does nothing for anxiety, depression, or PTSD. The reality is far more complicated. Decades of federal restrictions, limited research access, and synthetic substitutes have shaped the science. This breakdown exposes how incomplete data and selective interpretation continue to drive misleading headlines about cannabis and mental health.
Politicians and pundits warned that legal cannabis would unleash a crime wave. The data tell a different story. From Colorado’s violent crime trends to DOJ time-series research and statewide arrest declines, the evidence shows no consistent long-term surge tied to legalization. The numbers never matched the panic.
Arizona lawmakers are advancing legislation that would criminalize “excessive” marijuana odor detectable across property lines. Cannabis Lie Vol. 3 examines SB 1725 and SCR 1048, the proposed misdemeanor penalties, the legal implications of State v. Sisco, and why critics argue this is a backdoor attempt to reintroduce cannabis criminalization under the banner of nuisance law.
Workplace Wars continues in New Jersey, where Senate Bill S3452 would protect registered medical cannabis patients from metabolite-only drug test punishment. The proposal shifts the burden to employers, requiring proof by a preponderance of the evidence that lawful medical use caused on-duty impairment, backed by specific articulable symptoms. It also keeps the written notice and three-day explanation or retest process.